Helicos Prices IPO

Helicos Biosciences Corp., a Cambridge, Mass.-based DNA sequencing company, priced 5.4 million common shares at $9 per share, for an IPO take of approximately $48.6 million. It originally planned to price the shares at $13-$15 per share, and later lowered the target to $10-$11 per share. It will trade on the Nasdaq under ticker symbol HLCS, while UBS served as lead underwriter. Helicos had raised around $67 million in VC funding from firms like Flagship Ventures (20.6% pre-IPO stake), Atlas Venture (17.6%), Highland Capital Partners (17.6%), MPM Capital (12.9%) and Versant Ventures (9.9%). www.helicosbio.com